▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Plus

Neg

Email

Fifth Third Bancorp To Present At GS Conference; Webcast At 2:00 PM ET

By RTTNews Staff Writer ✉ | Published: 12/4/2018 1:04 PM ET

Fifth Third Bancorp (FITB) will present at the Goldman Sachs U.S. Financial Services Conference in New York City

The event is scheduled to begin at 2:00 PM ET on December 4, 2018.

To access the live webcast, log on to www.53.com

For comments and feedback contact: editorial@rttnews.com

New Drugs Approved In December

New Drugs Approved In December

PDUFA Biotech stocks Chemotherapy COVID19 vaccines heart failure lupus ARS

Biotech Stocks Facing FDA Decision In January 2021

New Drugs Approved In November

New Drugs Approved In November

Latest Updates on COVID-19

New US COVID Cases At Its Lowest Level In Nearly 5 Months

FDA Authorizes Emergency Use Of Johnson & Johnson's Single-dose COVID-19 Vaccine

FDA Says 'rapidly Works Toward' Emergency Use Approval Of J&J's Single-shot COVID-19 Vaccine

Johnson & Johnson Single-dose COVID Vaccine Safe And Effective: FDA

US COVID-19 Hospitalizations Declining At Slower Pace

Read More

COVID-19: Drugs in Development

RELATED NEWS

Fifth Third Bancorp Q4 Income Drops

Follow RTT

Editor's Pick
Most Read
Most Emailed

Chico's FAS Posts Wider Q4 Loss, Kohl's, Abercrombie & Fitch Profit Tops View

Robot-assisted Device Approved To Facilitate Transvaginal Hysterectomy

Canopy Growth Launches CBD Beverage Brand Quatreau In The U.S. - Quick Facts

Amazon Sued By Employee For Alleged Gender, Racial Discrimination

Quaker Rice Crisps Sweet Barbecue Flavor Recalled

Texas' Brazos Electric Power Cooperative Files For Bankruptcy

El Abuelito Recalls Several Cheese Products Due To Listeria Concerns

CAE To Buy L3Harris' Military Training Business For $1.05 Bln - Quick Facts

J&J Distributing Recalls Multiple Food Products For Listeria Concerns

FDA Authorizes Emergency Use Of Johnson & Johnson's Single-dose COVID-19 Vaccine

FDA Says 'rapidly Works Toward' Emergency Use Approval Of J&J's Single-shot COVID-19 Vaccine

Berkshire Q4 Profit Up 23%

GSK : Phase 2 Trial Of Otilimab In Hospitalized COVID-19 Patients Did Not Reach Significance

BridgeBio : FDA Approves NULIBRY To Reduce Risk Of Mortality In Patients With MoCD Type A

Regeneron Pharma Stops Placebo Group Enrollment For REGEN-COV On Advice From IDMC

Moderna Q4 Loss Widens

FDA Says No To ATNX And CRMD, Morphic Jumps On IBD Trial Data, INO's REVEAL 1 Meets Goals

Stock Alert: Lixte Biotechnology Up 55%

Dr. Reddy's Recalls Prescription Drug Blister Packages

Pfizer Says EMA Accepted Marketing Authorization Application For Growth Hormone Somatrogon

Endo International plc Q4 adjusted earnings of $0.75 per share

NuVasive, Inc. Q4 Adjusted Earnings Beat Estimates

Pfizer, BioNTech Initiate Study To Evaluate COVID-19 Booster And New Vaccine Variants

Eli Lilly: U.S. Govt. To Buy Min. 100K Doses Of Bamlanivimab 700 Mg, Etesevimab 1400 Mg Together

Canopy Growth Launches CBD Beverage Brand Quatreau In The U.S. - Quick Facts

EARNINGS SUMMARY: Details of Cleveland-Cliffs Inc. Q4 Earnings Report

Nielsen Holdings plc Q4 adjusted earnings Beat Estimates

Loblaw Companies Q4 adjusted earnings of C$1.26 per share

Keurig Dr Pepper Inc. Q4 adjusted earnings Miss Estimates

Canadian Imperial Bank of Commerce Q1 adjusted earnings of C$3.58 per share

Evraz Plc FY Pretax Profit Rises; Revenue Down 18.1%

Centrica Posts FY Profit

Anglo American FY20 Profit Declines; Revenue Up 3%

Munich Re Q4 Profit Declines; Issues FY21 Guidance

Getlink Posts Loss In FY; Revenue Down 24% - Quick Facts

Safran FY20 Profit Down, Proposes Dividend; Sees Higher Margin, Lower Organic Revenues In FY21